VOYA Investment Management
MRTX

VOYA Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

VOYA Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,853
Closed -$403K – 2924
2023
Q4 		$403K Sell
6,853
-16,692
-71% -$938K ﹤0.01% 2188
2023
Q3 		$1.03M Sell
23,545
-30
-0.1% -$1.07K ﹤0.01% 1617
2023
Q2 		$852K Buy
23,575
+138
+0.6% +$5.69K ﹤0.01% 1766
2023
Q1 		$871K Sell
23,437
-91
-0.4% -$4.09K ﹤0.01% 1731
2022
Q4 		$1.07M Sell
23,528
-18,742
-44% -$1.21M ﹤0.01% 1605
2022
Q3 		$2.95M Buy
42,270
+36,637
+650% +$2.71M ﹤0.01% 1168
2022
Q2 		$378K Sell
5,633
-12,298
-69% -$782K ﹤0.01% 2011
2022
Q1 		$1.47M Sell
17,931
-336
-2% -$34.4K ﹤0.01% 1255
2021
Q4 		$2.68M Buy
18,267
+6,891
+61% +$1.07M 0.01% 1039
2021
Q3 		$2.01M Sell
11,376
-217
-2% -$34.9K ﹤0.01% 1165
2021
Q2 		$1.87M Sell
11,593
-103,032
-90% -$16.5M ﹤0.01% 1239
2021
Q1 		$19.6M Buy
114,625
+14,643
+15% +$2.9M 0.04% 347
2020
Q4 		$22M Buy
99,982
+87,292
+688% +$18.9M 0.04% 323
2020
Q3 		$2.11M Hold
12,690
– – ﹤0.01% 1012
2020
Q2 		$1.45M Sell
12,690
-1,902
-13% -$184K ﹤0.01% 1126
2020
Q1 		$1.12M Buy
14,592
+1,017
+7% +$91.2K ﹤0.01% 1176
2019
Q4 		$1.75M Buy
13,575
+2,953
+28% +$285K ﹤0.01% 1160
2019
Q3 		$828K Buy
10,622
+703
+7% +$66K ﹤0.01% 1436
2019
Q2 		$1.02M Buy
9,919
+1,377
+16% +$107K ﹤0.01% 1351
2019
Q1 		$626K Buy
8,542
+101
+1% +$6.87K ﹤0.01% 1644
2018
Q4 		$358K Buy
8,441
+640
+8% +$25.5K ﹤0.01% 1931
2018
Q3 		$367K Buy
7,801
+772
+11% +$43K ﹤0.01% 2034
2018
Q2 		$347K Buy
+7,029
New +$265K ﹤0.01% 2063

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

VOYA Investment Management's MRTX Position: Q1 2024 in Review

VOYA Investment Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 6,853 shares — an estimated $403K sold.

VOYA Investment Management first reported a position in MRTX in Q2 2018 and held it in 23 quarters. The position peaked at $22M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • VOYA Investment Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 6,853 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $403K.
  • VOYA Investment Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 23 quarters.
  • VOYA Investment Management's Mirati Therapeutics, Inc. Common Stock position peaked at $22M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.